Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Piebaldism × masitinib × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Mastocytosis 3 Pancreatic Neoplasms 2 Recurrence 1 Pruritus 1 Piebaldism 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Metastatic Castrate Resistant Prostate Cancer 1 Mastocytosis, Systemic 1 Gastrointestinal Stromal Tumors 1 Gastro-intestinal Stromal Tumours 1 Gastro Intestinal Stromal Tumor 1 Colorectal Cancer Metastatic 1 Blushing 1

Interventions

Imatinib Mesylate 2 ponatinib 1 nilotinib 1 masitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00814073 2019-12-03

AB06006

AB Science

Phase 3 Completed

Blushing, Mastocytosis, Pruritus, Piebaldism, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡